| A 17.24:96-08 | Biotechnology: education and training |
| A 77.15 | Evaluation of New Canal Point Sugarcane Clones http://www.ars.usda.gov/is/np/canalpt/contents.htm |
| HE 20.3417: B52 | Biogenetics and Tissue Engineering |
| PREX 8.111/2: 993 | Biotechnology for the 21st Century: a report |
| PREX 8.111/2: 995 | Biotechnology for the 21st Century: new horizons |
| PREX 1.19:B 52/ST 4 V. 1-3 | Ethical Issues in Human Stem Cell Research http://purl.access.gpo.gov?GPO/LPS10147,10148 |
| PREX 1.19:B 52/C 62 | Cloning Human Beings: report and recommendations of the National Bioethics Advisory Commission |
| PREX 1.19: B 52/ET 3/EXEC. SUM. | Research Involving Human Biological Materials: Ethical Issues and Policy Guidance |
| Y 1.1/8:H. RPT. 105-239 | Human Cloning |
| Y 3. T 22/2: 2 B 52/5 | Biology, Medicine, and the Bill of Rights: special report |
| Y 3. T 22/2: 2 B 57/9 | Biotechnology in a Global Economy |
| Y 4. AG 8/1: 106-6 | Agricultural Biotechnology |
| Y 4. C 73/8: 105-70 | Cloning: legal, medical, ethical and social issues |
| Y 4. C 73/8: 107-5 | Issues Raised by Human Cloning Research |
| Y 4. J 89/1: 106/121 | Gene Patents and other Genomic Inventions |
| Y 4. J 89/2: S. HRG. 102-1134 | The Genome Project; the ethical issues of gene patenting |
| Y 4. L 11/4:S. HRG. 105-123 | Ethics and Theology |
| Y 4. SCI 2: 105/3 | Biotechnology and the Ethics of Cloning: how far should we go? |
| Y 4. SCI 2: 105/66 | The Human Genome Project: how private sector developments affect the government program |
| Y 4. SCI 2: 106-7 | Genetics Testing in the New Millenium: advances, standards, and implications |
| Y 4. SCI 2: 106-8 | The Human Genome Project: hearing before the Subcommittee on Energy and Environment |
